<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>50604724622750</udiDi>
    <basicUdiDi>B-50604724622750</basicUdiDi>
    <tradeName>Factor 55</tradeName>
    <deviceName>Factor 55</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6041</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:21:06.225Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724622682</udiDi>
    <basicUdiDi>B-50604724622682</basicUdiDi>
    <tradeName>Vi Factor</tradeName>
    <deviceName>Vi Factor</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6040</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:21:06.164Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724622514</udiDi>
    <basicUdiDi>B-50604724622514</basicUdiDi>
    <tradeName>Group S Factor 41</tradeName>
    <deviceName>Group S Factor 41</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6039</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:21:04.936Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724622446</udiDi>
    <basicUdiDi>B-50604724622446</basicUdiDi>
    <tradeName>Group R Factor 40</tradeName>
    <deviceName>Group R Factor 40</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6038</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:21:03.642Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724622378</udiDi>
    <basicUdiDi>B-50604724622378</basicUdiDi>
    <tradeName>Group Q Factor 39</tradeName>
    <deviceName>Group Q Factor 39</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6037</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:21:00.793Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724622200</udiDi>
    <basicUdiDi>B-50604724622200</basicUdiDi>
    <tradeName>Group P Factor 38</tradeName>
    <deviceName>Group P Factor 38</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6036</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:20:59.617Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724622132</udiDi>
    <basicUdiDi>B-50604724622132</basicUdiDi>
    <tradeName>Group O Factor 35</tradeName>
    <deviceName>Group O Factor 35</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6035</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:20:59.237Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724622064</udiDi>
    <basicUdiDi>B-50604724622064</basicUdiDi>
    <tradeName>Group N Factor 30</tradeName>
    <deviceName>Group N Factor 30</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6034</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:20:58.648Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724621906</udiDi>
    <basicUdiDi>B-50604724621906</basicUdiDi>
    <tradeName>Group M Factor 28</tradeName>
    <deviceName>Group M Factor 28</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6033</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:20:53.474Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724621838</udiDi>
    <basicUdiDi>B-50604724621838</basicUdiDi>
    <tradeName>Group L Factor 21</tradeName>
    <deviceName>Group L Factor 21</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6032</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:20:52.851Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724621760</udiDi>
    <basicUdiDi>B-50604724621760</basicUdiDi>
    <tradeName>Group K Factor 18</tradeName>
    <deviceName>Group K Factor 18</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6031</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:20:51.921Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724621692</udiDi>
    <basicUdiDi>B-50604724621692</basicUdiDi>
    <tradeName>Group J Factor 17</tradeName>
    <deviceName>Group J Factor 17</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6030</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:20:50.694Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724621524</udiDi>
    <basicUdiDi>B-50604724621524</basicUdiDi>
    <tradeName>Group I Factor 16</tradeName>
    <deviceName>Group I Factor 16</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6029</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:20:47.222Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724621456</udiDi>
    <basicUdiDi>B-50604724621456</basicUdiDi>
    <tradeName>Group C3 Factor 20</tradeName>
    <deviceName>Group C3 Factor 20</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6027</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:20:46.717Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724621388</udiDi>
    <basicUdiDi>B-50604724621388</basicUdiDi>
    <tradeName>Group G2 Factor 23</tradeName>
    <deviceName>Group G2 Factor 23</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6025</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:20:46.432Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724621210</udiDi>
    <basicUdiDi>B-50604724621210</basicUdiDi>
    <tradeName>Group G1 Factor 22</tradeName>
    <deviceName>Group G1 Factor 22</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6024</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:20:45.841Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724621142</udiDi>
    <basicUdiDi>B-50604724621142</basicUdiDi>
    <tradeName>Group G Factor 13, 22, 23</tradeName>
    <deviceName>Group G Factor 13, 22, 23</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6023</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:20:40.432Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724621074</udiDi>
    <basicUdiDi>B-50604724621074</basicUdiDi>
    <tradeName>Group F Factor 11</tradeName>
    <deviceName>Group F Factor 11</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6022</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:20:38.958Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724620916</udiDi>
    <basicUdiDi>B-50604724620916</basicUdiDi>
    <tradeName>Group E3 Factor 34</tradeName>
    <deviceName>Group E3 Factor 34</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6021</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:20:37.880Z</lastUpdated>
  </row>
  <row>
    <udiDi>50604724620848</udiDi>
    <basicUdiDi>B-50604724620848</basicUdiDi>
    <tradeName>Group E4 Factor 19</tradeName>
    <deviceName>Group E4 Factor 19</deviceName>
    <manufacturerName>Pro-Lab Diagnostics UK</manufacturerName>
    <manufacturerSrn>GB-MF-000003833</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01029001</emdnCode>
    <emdnDescription>ANTISERA (MONOVALENT AND POLYVALENT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PL.6020</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T23:20:37.079Z</lastUpdated>
  </row>
</eudamedExport>